Register Cart 0

Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5230
ISSN (Online): 1875-614X

Back Subscribe

Editorial [Hot Topic:Mimetic Peptides in Allergy and Inflammation Treatment (Guest Editor: Demitrios H. Vynios)]

Author(s): Demitrios H. Vynios

Volume 7, Issue 4, 2008

Page: [239 - 239] Pages: 1

DOI: 10.2174/187152308786847834

Next »

Rights & Permissions Print Cite

Article Metrics

13

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Methylene Blue and Vasoplegia: Who, When, and How?
Mini-Reviews in Medicinal Chemistry

Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria
Inflammation & Allergy - Drug Targets (Discontinued)

Occupational Allergy in Healthcare Workers
Recent Patents on Inflammation & Allergy Drug Discovery

Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design

Effects of Amine Oxidases in Allergic and Histamine-Mediated Conditions
Recent Patents on Inflammation & Allergy Drug Discovery

Intravenous Immunoglobulin as a Potential Therapy for Refractory Urticaria - A Review
Inflammation & Allergy - Drug Targets (Discontinued)

Genetic Predictors of Drug Hypersensitivity
Current Pharmaceutical Design

Understanding and Avoiding Antiretroviral Adverse Events
Current Pharmaceutical Design

Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews

The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications
Current Rheumatology Reviews

Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety

Perception of Symptoms in Hypertensive Patients and the Relevance to the Application of Anti- Hypertensive Drug Therapy
Current Pharmaceutical Design

Basophil Activation Test with Indomethacin to Assess Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs: A Preliminary Study
Inflammation & Allergy - Drug Targets (Discontinued)

Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?)
Current Vascular Pharmacology

Pharmacologically Targeting the Primary Defect and Downstream Pathology in Duchenne Muscular Dystrophy
Current Gene Therapy

Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery

Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets

Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry

Proniosomes in Transdermal Drug Delivery
Current Pharmaceutical Design

Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery

© 2025 Bentham Science Publishers | Privacy Policy